Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation
Ying Qiang Shen, Ana Guerra-Librero, Beatriz I. Fernandez-Gil, Javier Florido, Sergio García-López, Laura Martinez-Ruiz, Miguel Mendivil-Perez, Viviana Soto-Mercado, Darío Acuña-Castroviejo, Hector Ortega-Arellano, Victor Carriel, María E. Diaz-Casado, Russel J. Reiter, Iryna Rusanova, Ana Nieto, Luis C. López, Germaine Escames*
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
149Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation'. Together they form a unique fingerprint.